by Elena Iemma | Mar 1, 2025 | Blog
The EpiVax team is dedicated to advancing the science of immunogenicity assessment and streamlining the preclinical drug development process for our partners worldwide. This month, we’re excited to share several updates with you, including new and updated in silico...
by Elena Iemma | Feb 24, 2025 | Blog
We know, and We Care There is not a lot of room in the TOL (Thinking out Loud) Newsletter to share our feelings about the news in the USA, but we want you to know that we ARE aware, and we REALLY CARE about the negative impact of recent...
by Elena Iemma | Jan 22, 2025 | Blog
Regulatory T Cells and Immune Tolerance in Biologic Drug Development The recent Nobel Prize recognition of discoveries in immune tolerance highlights how far regulatory T cell biology has progressed, from foundational immunology to active therapeutic development....
by Elena Iemma | Jan 22, 2025 | Blog
Applying Immunoinformatics to Animal Health We were thrilled to have a visit by Julia Baker (U of Minn Vet School) last week! She gave a terrific talk to the Epi-team on the evolution of Porcine Reproductive and Respiratory Syndrome virus...
by Elena Iemma | Dec 19, 2024 | Blog
Even more Fearless in 2025 2024 was a year of transformation and momentum for us—a real steppingstone to EpiVax 2.0. We are grateful to our new CEO, Rich-Henry Schabowsky, for creating a work environment where innovation moves...
by Elena Iemma | Nov 19, 2024 | Blog
Talking out loud to myself (and about 7000 friends) It’s the time of year for gratitude As we approach the season of gratitude, I would like to THANK YOU, our colleagues in the immunogenicity space, who are “Science Forward”....
